EPO published patent application EP3697391A1 for mini-tablet pharmaceutical formulations assigned to IPC class A61K 9/20. The applicants are DFE Pharma GmbH & Co. KG with four named inventors. The patent is designated across 35 European member states including AT, BE, DE, FR, GB, IT, NL, ES, PL, and others.

This is a routine patent publication notice with no compliance requirements. Pharmaceutical companies and drug manufacturers should monitor EPO patent publications in their therapeutic areas to identify potential blocking patents. Competitors developing mini-tablet formulations should review this publication for freedom-to-operate implications.